The domestic manufacturing sector is currently passing through a difficult phase with global economic slowdown. The post-WTO economic order with fierce global competition in every aspect of economic activity is also effecting the industry. Some of the major issues being faced by the industry in the chemical sector are – cost of power, duty free import of equipment and lack of adequate infrastructure. As far as the petrochemical sector is concerned, the pending issues include - reduction in import duty on capital goods, continuation of small scale industries reservation in the economy, technology up-gradation fund scheme, rationalization of excise duty on fibres/yarns, strengthening of Directorate of Anti-dumping and allied duties as well as disposal of plastic goods. As far as the pharmaceutical sector is concerned, the issues of importance are formation of separate export promotion council for pharmaceuticals "PHARMEXCIL", stability in Government policies pertaining to exports and simplification of procedures relating to customs and excise.

        The discussions would have participation from other ministries like Finance, Environment & Forests, Health, Industry, Commerce, Agriculture & Cooperation, Labour etc. The industry would be represented by Ranbaxy Laboratories, Orchid Chemicals & Pharmaceuticals Ltd., IPCA Laboratories, Dr. Reddy’s Labs, Sun Pharma Ltd., Lupin Laboratories, Dabur, Glaxo and Cipla, etc. There would be representation from Indian Chemicals Manufacturers Association, Pesticides Association of India, Alkali Manufacturers’ Association of India and Association of Small & Medium Chemical Manufacturers, etc. FICCI, CII and ASSOCHAM would also be represent.